My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Clinical trial NCT02091141 · COMPLETED
Trial details
- NCT number
- NCT02091141
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-14
- Primary completion
- 2023-05-24
- Enrollment
- 673
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.